Amgen AMGN
NASDAQ AMGN
$385.65 +5.87 (+1.55%)
At close: Sep 18, 2026 · 4:00 PM EDT

Amgen (AMGN) Goodwill & Intangibles (2009 - 2026)

Amgen (AMGN) posted Goodwill & Intangibles of $39.2 billion for Q2 2026, down 2.24% on a QoQ basis from $40.1 billion in Q1 2026, and down 9.55% year-over-year from $43.3 billion in Q2 2025.

Analysis

Amgen (AMGN) Goodwill & Intangibles (2009 - 2026) Analysis & Trends

Amgen has reported Goodwill & Intangibles for 18 years, with the latest figure at $39.2 billion in Q2 2026.

  • On a quarterly basis, Goodwill & Intangibles fell 9.55% year-over-year to $39.2 billion in Q2 2026; TTM through Jun 2026 was $39.2 billion, a 9.55% decrease from a year earlier, with the FY2025 full-year figure at $41.0 billion, down 11.61% from the prior year.
  • Goodwill & Intangibles was $39.2 billion for Q2 2026 at Amgen, down from $40.1 billion in the prior quarter.
  • The five-year high for Goodwill & Intangibles was $51.3 billion in Q4 2023, with the low at $28.1 billion in Q3 2022.
  • Average Goodwill & Intangibles over 5 years is $39.0 billion, with a median of $40.5 billion recorded in 2025.
  • The sharpest annual moves came in 2024 and 2025: Goodwill & Intangibles surged 66.01% in 2024, then retreated 12.11% in 2025.
  • Over 5 years, Goodwill & Intangibles stood at $31.6 billion in 2022, then jumped by 62.2% to $51.3 billion in 2023, then decreased by 9.62% to $46.3 billion in 2024, then decreased by 11.61% to $41.0 billion in 2025, then slipped by 4.4% to $39.2 billion in 2026.
  • The last three Goodwill & Intangibles figures came in at $39.2 billion (Q2 2026), $40.1 billion (Q1 2026), and $41.0 billion (Q4 2025), per Business Quant data.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Amgen 208.48 Bn 194.49 Bn 7.24 Bn
2 Gilead Sciences 186.29 Bn 183.02 Bn 6.22 Bn
3 Vertex Pharmaceuticals 128.79 Bn 120.93 Bn 2.84 Bn
4 Regeneron Pharmaceuticals 80.66 Bn 72.67 Bn 3.93 Bn
5 Moderna 61.46 Bn 56.32 Bn 52.00 Mn
6 Argenx Se 61.28 Bn 56.10 Bn 1.37 Bn
7 Alnylam Pharmaceuticals 32.04 Bn 28.73 Bn 992.69 Mn
8 Biogen 31.84 Bn 30.56 Bn 1.96 Bn
9 Roivant Sciences 28.74 Bn 29.43 Bn 1.16 Mn
10 Insmed 26.19 Bn 25.03 Bn 358.27 Mn
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2026 39.16 Bn
Mar 31, 2026 40.05 Bn
Dec 31, 2025 40.96 Bn
Sep 30, 2025 41.82 Bn
Jun 30, 2025 43.29 Bn
Mar 31, 2025 44.37 Bn
Dec 31, 2024 46.34 Bn
Sep 30, 2024 47.58 Bn
Jun 30, 2024 48.79 Bn
Mar 31, 2024 49.94 Bn
Dec 31, 2023 51.27 Bn
Sep 30, 2023 28.66 Bn
Jun 30, 2023 30.16 Bn
Mar 31, 2023 30.92 Bn
Dec 31, 2022 31.61 Bn
Sep 30, 2022 28.11 Bn
Jun 30, 2022 28.79 Bn
Mar 31, 2022 29.46 Bn
Dec 31, 2021 30.07 Bn
Sep 30, 2021 29.32 Bn